{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:29:43Z","timestamp":1790483383655,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2051-5960-2-9","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T16:13:48Z","timestamp":1390493628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer\u2019s disease pathogenesis"],"prefix":"10.1186","volume":"2","author":[{"given":"Timothy A","family":"Couttas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Kain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Ying","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Kril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Pickford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S","family":"Don","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,23]]},"reference":[{"key":"88_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP: The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013, 9: 63\u201375. e2 10.1016\/j.jalz.2012.11.007","journal-title":"Alzheimers Dement"},{"issue":"9","key":"88_CR2","first-page":"208","volume":"2013","author":"W Thies","year":"2013","unstructured":"Thies W, Bleiler L, Alzheimer's A: Alzheimer's disease facts and figures. Alzheimers Dement 2013, 2013(9):208\u2013245.","journal-title":"Alzheimers Dement"},{"key":"88_CR3","first-page":"77sr1","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM, Morris JC, Goate AM: Alzheimer's disease: the challenge of the second century. Sci Transl Med 2011, 3: 77sr1.","journal-title":"Sci Transl Med"},{"key":"88_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW: Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990, 27: 457\u2013464. 10.1002\/ana.410270502","journal-title":"Ann Neurol"},{"key":"88_CR5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ: Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2006, 27: 1372\u20131384. 10.1016\/j.neurobiolaging.2005.09.012","journal-title":"Neurobiol Aging"},{"key":"88_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E: Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995, 16: 271\u2013278. discussion 78\u201384 10.1016\/0197-4580(95)00021-6","journal-title":"Neurobiol Aging"},{"key":"88_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/2051-5960-1-62","volume":"1","author":"D Krstic","year":"2013","unstructured":"Krstic D, Knuesel I: The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease. Acta Neuropathol Commun 2013, 1: 62. 10.1186\/2051-5960-1-62","journal-title":"Acta Neuropathol Commun"},{"key":"88_CR8","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","volume":"19","author":"L Crews","year":"2010","unstructured":"Crews L, Masliah E: Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 2010, 19: R12-R20. 10.1093\/hmg\/ddq160","journal-title":"Hum Mol Genet"},{"key":"88_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1517\/14728214.2012.675327","volume":"17","author":"A Corbett","year":"2012","unstructured":"Corbett A, Ballard C: New and emerging treatments for Alzheimer's disease. Expert Opin Emerg Drugs 2012, 17: 147\u2013156. 10.1517\/14728214.2012.675327","journal-title":"Expert Opin Emerg Drugs"},{"key":"88_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1194\/jlr.M400486-JLR200","volume":"46","author":"RM Lane","year":"2005","unstructured":"Lane RM, Farlow MR: Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 2005, 46: 949\u2013968. 10.1194\/jlr.M400486-JLR200","journal-title":"J Lipid Res"},{"key":"88_CR11","first-page":"806","volume":"2010","author":"JE Vance","year":"1801","unstructured":"Vance JE, Hayashi H: Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta 1801, 2010: 806\u2013818.","journal-title":"Biochim Biophys Acta"},{"key":"88_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261: 921\u2013923. 10.1126\/science.8346443","journal-title":"Science"},{"key":"88_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al.: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994, 7: 180\u2013184. 10.1038\/ng0694-180","journal-title":"Nat Genet"},{"key":"88_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, et al.: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009, 41: 1088\u20131093. 10.1038\/ng.440","journal-title":"Nat Genet"},{"key":"88_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, et al.: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009, 41: 1094\u20131099. 10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"88_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, et al.: Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011, 43: 429\u2013435. 10.1038\/ng.803","journal-title":"Nat Genet"},{"key":"88_CR17","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1111\/j.1471-4159.2007.04958.x","volume":"103","author":"K Sato","year":"2007","unstructured":"Sato K, Malchinkhuu E, Horiuchi Y, Mogi C, Tomura H, Tosaka M, Yoshimoto Y, Kuwabara A, Okajima F: Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. J Neurochem 2007, 103: 2610\u20132619.","journal-title":"J Neurochem"},{"key":"88_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bbrc.2007.05.131","volume":"359","author":"K Sato","year":"2007","unstructured":"Sato K, Malchinkhuu E, Horiuchi Y, Mogi C, Tomura H, Tosaka M, Yoshimoto Y, Kuwabara A, Okajima F: HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate. Biochem Biophys Res Commun 2007, 359: 649\u2013654. 10.1016\/j.bbrc.2007.05.131","journal-title":"Biochem Biophys Res Commun"},{"key":"88_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S: Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 2012, 22: 50\u201360. 10.1016\/j.tcb.2011.09.003","journal-title":"Trends Cell Biol"},{"key":"88_CR20","first-page":"20","volume":"2013","author":"JW Choi","year":"1831","unstructured":"Choi JW, Chun J: Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta 1831, 2013: 20\u201332.","journal-title":"Biochim Biophys Acta"},{"key":"88_CR21","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","volume":"25","author":"K Mizugishi","year":"2005","unstructured":"Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL: Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005, 25: 11113\u201311121. 10.1128\/MCB.25.24.11113-11121.2005","journal-title":"Mol Cell Biol"},{"key":"88_CR22","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/381800a0","volume":"381","author":"O Cuvillier","year":"1996","unstructured":"Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996, 381: 800\u2013803. 10.1038\/381800a0","journal-title":"Nature"},{"key":"88_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.nbd.2006.02.010","volume":"23","author":"C Malaplate-Armand","year":"2006","unstructured":"Malaplate-Armand C, Florent-Bechard S, Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier JL, Oster T, Pillot T: Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis 2006, 23: 178\u2013189. 10.1016\/j.nbd.2006.02.010","journal-title":"Neurobiol Dis"},{"key":"88_CR24","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1128\/MCB.01465-06","volume":"27","author":"T Kajimoto","year":"2007","unstructured":"Kajimoto T, Okada T, Yu H, Goparaju SK, Jahangeer S, Nakamura S: Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol Cell Biol 2007, 27: 3429\u20133440. 10.1128\/MCB.01465-06","journal-title":"Mol Cell Biol"},{"key":"88_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.neuroscience.2010.10.021","volume":"171","author":"T Kanno","year":"2010","unstructured":"Kanno T, Nishizaki T, Proia RL, Kajimoto T, Jahangeer S, Okada T, Nakamura S: Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus. Neuroscience 2010, 171: 973\u2013980. 10.1016\/j.neuroscience.2010.10.021","journal-title":"Neuroscience"},{"key":"88_CR26","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1101\/gad.188003.112","volume":"26","author":"JP Chan","year":"2012","unstructured":"Chan JP, Hu Z, Sieburth D: Recruitment of sphingosine kinase to presynaptic terminals by a conserved muscarinic signaling pathway promotes neurotransmitter release. Genes Dev 2012, 26: 1070\u20131085. 10.1101\/gad.188003.112","journal-title":"Genes Dev"},{"key":"88_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1126\/science.1070238","volume":"296","author":"S Mandala","year":"2002","unstructured":"Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296: 346\u2013349. 10.1126\/science.1070238","journal-title":"Science"},{"key":"88_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2165\/11207350-000000000-00000","volume":"25","author":"LJ Scott","year":"2011","unstructured":"Scott LJ: Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis. CNS Drugs 2011, 25: 673\u2013698. 10.2165\/11207350-000000000-00000","journal-title":"CNS Drugs"},{"key":"88_CR29","doi-asserted-by":"publisher","first-page":"21453","DOI":"10.1074\/jbc.C200176200","volume":"277","author":"V Brinkmann","year":"2002","unstructured":"Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277: 21453\u201321457. 10.1074\/jbc.C200176200","journal-title":"J Biol Chem"},{"key":"88_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1600-065X.2008.00645.x","volume":"223","author":"H Rosen","year":"2008","unstructured":"Rosen H, Gonzalez-Cabrera P, Marsolais D, Cahalan S, Don AS, Sanna MG: Modulating tone: the overture of S1P receptor immunotherapeutics. Immunol Rev 2008, 223: 221\u2013235. 10.1111\/j.1600-065X.2008.00645.x","journal-title":"Immunol Rev"},{"key":"88_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1073\/pnas.1014154108","volume":"108","author":"JW Choi","year":"2011","unstructured":"Choi JW, Gardell SE, Herr DR, Rivera R, Lee CW, Noguchi K, Teo ST, Yung YC, Lu M, Kennedy G, Chun J: FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A 2011, 108: 751\u2013756. 10.1073\/pnas.1014154108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"88_CR32","doi-asserted-by":"publisher","first-page":"e61988","DOI":"10.1371\/journal.pone.0061988","volume":"8","author":"Y Doi","year":"2013","unstructured":"Doi Y, Takeuchi H, Horiuchi H, Hanyu T, Kawanokuchi J, Jin S, Parajuli B, Sonobe Y, Mizuno T, Suzumura A: Fingolimod phosphate attenuates oligomeric amyloid beta-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons. PLoS One 2013, 8: e61988. 10.1371\/journal.pone.0061988","journal-title":"PLoS One"},{"key":"88_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s12031-013-9979-6","volume":"50","author":"M Asle-Rousta","year":"2013","unstructured":"Asle-Rousta M, Kolahdooz Z, Oryan S, Ahmadiani A, Dargahi L: FTY720 (fingolimod) attenuates beta-amyloid peptide (Abeta42)-induced impairment of spatial learning and memory in rats. J Mol Neurosci 2013, 50: 524\u2013532. 10.1007\/s12031-013-9979-6","journal-title":"J Mol Neurosci"},{"key":"88_CR34","doi-asserted-by":"publisher","first-page":"e64050","DOI":"10.1371\/journal.pone.0064050","volume":"8","author":"N Takasugi","year":"2013","unstructured":"Takasugi N, Sasaki T, Ebinuma I, Osawa S, Isshiki H, Takeo K, Tomita T, Iwatsubo T: FTY720\/fingolimod, a sphingosine analogue, reduces amyloid-beta production in neurons. PLoS One 2013, 8: e64050. 10.1371\/journal.pone.0064050","journal-title":"PLoS One"},{"key":"88_CR35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He X, Huang Y, Li B, Gong CX, Schuchman EH: Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging 2010, 31: 398\u2013408. 10.1016\/j.neurobiolaging.2008.05.010","journal-title":"Neurobiol Aging"},{"key":"88_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/PL00007425","volume":"99","author":"AJ Harding","year":"2000","unstructured":"Harding AJ, Kril JJ, Halliday GM: Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol 2000, 99: 199\u2013208. 10.1007\/PL00007425","journal-title":"Acta Neuropathol"},{"key":"88_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ: National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012, 8: 1\u201313. 10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"key":"88_CR38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3233\/JAD-122278","volume":"35","author":"S Bhatia","year":"2013","unstructured":"Bhatia S, Jenner AM, Li H, Ruberu K, Spiro AS, Shepherd CE, Kril JJ, Kain N, Don A, Garner B: Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels. J Alzheimers Dis 2013, 35: 475\u2013486.","journal-title":"J Alzheimers Dis"},{"key":"88_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1021\/ac2026578","volume":"84","author":"JWH Wong","year":"2012","unstructured":"Wong JWH, Abuhusain HJ, McDonald KL, Don AS: MMSAT: automated quantification of metabolites in selected reaction monitoring experiments. Anal Chem 2012, 84: 470\u2013474. 10.1021\/ac2026578","journal-title":"Anal Chem"},{"key":"88_CR40","doi-asserted-by":"publisher","first-page":"15833","DOI":"10.1074\/jbc.M609124200","volume":"282","author":"AS Don","year":"2007","unstructured":"Don AS, Martinez-Lamenca C, Webb WR, Proia RL, Roberts E, Rosen H: Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. J Biol Chem 2007, 282: 15833\u201315842. 10.1074\/jbc.M609124200","journal-title":"J Biol Chem"},{"key":"88_CR41","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1016\/j.febslet.2007.05.069","volume":"581","author":"D Mechtcheriakova","year":"2007","unstructured":"Mechtcheriakova D, Wlachos A, Sobanov J, Bornancin F, Zlabinger G, Baumruker T, Billich A: FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3. FEBS Lett 2007, 581: 3063\u20133068. 10.1016\/j.febslet.2007.05.069","journal-title":"FEBS Lett"},{"key":"88_CR42","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227: 680\u2013685. 10.1038\/227680a0","journal-title":"Nature"},{"key":"88_CR43","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","volume":"76","author":"H Towbin","year":"1979","unstructured":"Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979, 76: 4350\u20134354. 10.1073\/pnas.76.9.4350","journal-title":"Proc Natl Acad Sci U S A"},{"key":"88_CR44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","volume":"29","author":"V Filippov","year":"2012","unstructured":"Filippov V, Song MA, Zhang K, Vinters HV, Tung S, Kirsch WM, Yang J, Duerksen-Hughes PJ: Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J Alzheimers Dis 2012, 29: 537\u2013547.","journal-title":"J Alzheimers Dis"},{"key":"88_CR45","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP: Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 2004, 101: 2070\u20132075. 10.1073\/pnas.0305799101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"88_CR46","doi-asserted-by":"publisher","first-page":"19513","DOI":"10.1074\/jbc.M002759200","volume":"275","author":"H Liu","year":"2000","unstructured":"Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S: Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 2000, 275: 19513\u201319520. 10.1074\/jbc.M002759200","journal-title":"J Biol Chem"},{"key":"88_CR47","doi-asserted-by":"publisher","first-page":"34541","DOI":"10.1074\/jbc.M301741200","volume":"278","author":"KR Johnson","year":"2003","unstructured":"Johnson KR, Johnson KY, Becker KP, Bielawski J, Mao C, Obeid LM: Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. J Biol Chem 2003, 278: 34541\u201334547. 10.1074\/jbc.M301741200","journal-title":"J Biol Chem"},{"key":"88_CR48","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1074\/jbc.M209514200","volume":"278","author":"C Ogawa","year":"2003","unstructured":"Ogawa C, Kihara A, Gokoh M, Igarashi Y: Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J Biol Chem 2003, 278: 1268\u20131272. 10.1074\/jbc.M209514200","journal-title":"J Biol Chem"},{"key":"88_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR: Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004, 13: 159\u2013170.","journal-title":"Hum Mol Genet"},{"key":"88_CR50","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L: High-level neuronal expression of abeta 1\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000, 20: 4050\u20134058.","journal-title":"J Neurosci"},{"key":"88_CR51","volume-title":"Biochim Biophys Acta","author":"K Yuyama","year":"2013","unstructured":"Yuyama K, Mitsutake S, Igarashi Y: Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer's disease. Biochim Biophys Acta 2013. in press"},{"key":"88_CR52","doi-asserted-by":"publisher","first-page":"21384","DOI":"10.1074\/jbc.M112.340513","volume":"287","author":"G Wang","year":"2012","unstructured":"Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, Mayer-Proschel M, Bieberich E: Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 2012, 287: 21384\u201321395. 10.1074\/jbc.M112.340513","journal-title":"J Biol Chem"},{"key":"88_CR53","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"X Han","year":"2002","unstructured":"Han X, MH D, McKeel DW Jr, Kelley J, Morris JC: Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 2002, 82: 809\u2013818. 10.1046\/j.1471-4159.2002.00997.x","journal-title":"J Neurochem"},{"key":"88_CR54","doi-asserted-by":"publisher","first-page":"32563","DOI":"10.1074\/jbc.M113.483750","volume":"288","author":"Y Xiong","year":"2013","unstructured":"Xiong Y, Lee HJ, Mariko B, Lu YC, Dannenberg AJ, Haka AS, Maxfield FR, Camerer E, Proia RL, Hla T: Sphingosine kinases are not required for inflammatory responses in macrophages. J Biol Chem 2013, 288: 32563\u201332573. 10.1074\/jbc.M113.483750","journal-title":"J Biol Chem"},{"key":"88_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/BJ20120609","volume":"447","author":"Y Kharel","year":"2012","unstructured":"Kharel Y, Raje M, Gao M, Gellett AM, Tomsig JL, Lynch KR, Santos WL: Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. Biochem J 2012, 447: 149\u2013157. 10.1042\/BJ20120609","journal-title":"Biochem J"},{"key":"88_CR56","doi-asserted-by":"publisher","first-page":"e23905","DOI":"10.1371\/journal.pone.0023905","volume":"6","author":"I Fischer","year":"2011","unstructured":"Fischer I, Alliod C, Martinier N, Newcombe J, Brana C, Pouly S: Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS One 2011, 6: e23905. 10.1371\/journal.pone.0023905","journal-title":"PLoS One"},{"key":"88_CR57","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1471-4159.2007.04755.x","volume":"103","author":"N Blondeau","year":"2007","unstructured":"Blondeau N, Lai Y, Tyndall S, Popolo M, Topalkara K, Pru JK, Zhang L, Kim H, Liao JK, Ding K, Waeber C: Distribution of sphingosine kinase activity and mRNA in rodent brain. J Neurochem 2007, 103: 509\u2013517. 10.1111\/j.1471-4159.2007.04755.x","journal-title":"J Neurochem"},{"key":"88_CR58","doi-asserted-by":"publisher","first-page":"52487","DOI":"10.1074\/jbc.M406512200","volume":"279","author":"ML Allende","year":"2004","unstructured":"Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G, Hajdu R, Rosenbach M, Keohane CA, Mandala S, Spiegel S, Proia RL: Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 2004, 279: 52487\u201352492. 10.1074\/jbc.M406512200","journal-title":"J Biol Chem"},{"key":"88_CR59","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1523\/JNEUROSCI.6467-10.2011","volume":"31","author":"N Takasugi","year":"2011","unstructured":"Takasugi N, Sasaki T, Suzuki K, Osawa S, Isshiki H, Hori Y, Shimada N, Higo T, Yokoshima S, Fukuyama T, Lee VM, Trojanowski JQ, Tomita T, Iwatsubo T: BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J Neurosci 2011, 31: 6850\u20136857. 10.1523\/JNEUROSCI.6467-10.2011","journal-title":"J Neurosci"},{"key":"88_CR60","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","volume":"114","author":"G Theilmeier","year":"2006","unstructured":"Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B: High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006, 114: 1403\u20131409. 10.1161\/CIRCULATIONAHA.105.607135","journal-title":"Circulation"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2051-5960-2-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T14:34:20Z","timestamp":1716474860000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-2-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,23]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-2-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,23]]},"assertion":[{"value":"18 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}